Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Clinical trial NCT07162090 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07162090
Sponsor: Tianjin Medical University General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sarcopenia Anemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients

Start date: 2025-09-10
Primary completion: 2026-09-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.